Vascular endothelial growth factor C ( VEGFC ) and vascular endothelial growth factor receptor 1 ( VEGFR1 ) mRNA overexpression has recently been shown to have strong predictive and prognostic value in patients with high-risk early breast cancer undergoing adjuvant chemotherapy .